HK-listed pharmaceutical company China NT Pharma Group Company Limited has entered into an agreement to acquire a 40 per cent stake in Beijing Konruns Pharmaceutical’s unit Kangchen for 360 million yuan ($51 million) in a bid to reshuffle its business.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
